Boehringer Ingelheim’s lung disease drug nerandomilast has been successful in a Phase III study paving the way for the ...

The falsehoods and fearmongering could jeopardise the public response to a future pandemic, researchers warn. Read more at ...

North Carolina's top research universities could lose millions of dollars in support if a Trump administration revision to ...